Aterian, Inc. (NASDAQ:ATER) Short Interest Down 9.1% in September

Aterian, Inc. (NASDAQ:ATERGet Free Report) saw a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 263,200 shares, a decrease of 9.1% from the September 15th total of 289,600 shares. Based on an average daily trading volume, of 61,000 shares, the short-interest ratio is currently 4.3 days. Currently, 4.0% of the company’s stock are short sold.

Insider Transactions at Aterian

In related news, Director William Kurtz sold 8,547 shares of Aterian stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $3.01, for a total value of $25,726.47. Following the sale, the director now owns 47,216 shares of the company’s stock, valued at approximately $142,120.16. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director William Kurtz sold 8,547 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $3.01, for a total value of $25,726.47. Following the completion of the transaction, the director now directly owns 47,216 shares of the company’s stock, valued at approximately $142,120.16. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CTO Roi Zion Zahut sold 14,050 shares of the company’s stock in a transaction on Wednesday, September 11th. The stock was sold at an average price of $3.06, for a total transaction of $42,993.00. Following the sale, the chief technology officer now directly owns 201,494 shares in the company, valued at $616,571.64. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 49,015 shares of company stock worth $150,562 in the last three months. Insiders own 4.70% of the company’s stock.

Institutional Trading of Aterian

Hedge funds have recently modified their holdings of the stock. B. Riley Wealth Advisors Inc. raised its holdings in Aterian by 39.8% in the 1st quarter. B. Riley Wealth Advisors Inc. now owns 24,750 shares of the company’s stock valued at $68,000 after acquiring an additional 7,050 shares during the period. XTX Topco Ltd acquired a new position in shares of Aterian in the second quarter valued at approximately $59,000. Finally, Essex Investment Management Co. LLC bought a new position in shares of Aterian during the third quarter worth approximately $102,000. Institutional investors and hedge funds own 7.02% of the company’s stock.

Aterian Stock Performance

Aterian stock opened at $3.06 on Tuesday. The stock has a 50-day simple moving average of $3.03 and a 200 day simple moving average of $2.74. The stock has a market capitalization of $26.25 million, a P/E ratio of -0.37 and a beta of 2.04. Aterian has a 52 week low of $1.90 and a 52 week high of $6.54.

Aterian (NASDAQ:ATERGet Free Report) last posted its earnings results on Thursday, August 8th. The company reported ($0.52) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.64) by $0.12. Aterian had a negative return on equity of 64.24% and a negative net margin of 18.88%. The business had revenue of $27.98 million for the quarter.

About Aterian

(Get Free Report)

Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.

See Also

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.